Alco Pharma

Alco Pharma, a significant entity in the Pharmaceutical and Healthcare sectors, began its journey in 1978 as an importer and distributor for MSD USA. This initial phase concluded in 1986, leading to a joint venture with MSD for a manufacturing facility in Mirpur, Dhaka. Following MSD's departure from Bangladesh in 1987, Alco Pharma acquired their assets, transitioning into a drug manufacturer. The company established a state-of-the-art pharmaceutical facility and, in 1991, obtained a Manufacturing License for biological and non-biological preparations, strictly adhering to WHO cGMP standards.

Currently, Alco Pharma is dedicated to researching, developing, manufacturing, and marketing a comprehensive range of pharmaceutical formulations. Their product portfolio addresses critical health needs, including treatments for antihypertensive, lipid-lowering, antidiabetic, antiasthmatic, and antibacterial conditions, alongside injectable medications and other life-enhancing products. Operating from a single location in Dhaka, Bangladesh, the company employs between 1,000 and 5,000 professionals. Alco Pharma prioritizes innovation and quality, continuously expanding its cGMP-compliant infrastructure and IT backbone to achieve its corporate mission. Meet Alco Pharma's team to learn more about their dedicated workforce.

With a reported revenue of $675.1M, Alco Pharma demonstrates a substantial market presence. Its commitment to rigorous quality control and cGMP compliance ensures the delivery of essential medicines. The company's focus on research and development drives the creation of advanced formulations to meet diverse patient needs across the Asia Pacific region. Alco Pharma's integrated operational model, from R&D to marketing, underscores its dedication to advancing healthcare solutions and improving lives through pharmaceutical innovation.